IP Library › Granted Patent US 10,927,139
Granted Patent B2
US 10,927,139 · App. 14/646,619 · Granted Feb 23, 2021

Chemically cleavable group

Inventors: Marc Stefan Robillard (Eindhoven, NL); Ronny Mathieu Versteegen (Eindhoven, NL); Wolter ten Hoeve (Eindhoven, NL); Raffaella Rossin (Eindhoven, NL)
Assignee: TAGWORKS PHARMACEUTICALS B.V.
C07H15/252A61K47/555A61K47/60A61K47/6897B82Y5/00C07C29/10C07C37/50C07C45/61C07C205/20C07C205/57C07C209/62G01N33/54353G01N33/60
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,927,139
App. No.
14/646,619
Granted
Feb 23, 2021
Kind
B2
Abstract

Disclosed is the use of the reactive components of the inverse electron-demand Diels Alder reaction for chemical masking and unmasking in vitro. This can be applied in complex chemical reactions and, particularly in the synthesis of biomolecules, e.g. on solid supports. The reactive components are a dienophile, particularly a trans-cyclooctene, and a diene, particularly a tetrazine.

Claims (50)

1. A method for provoking the release, in vitro, of a construct attached to a chemically cleavable group, wherein the chemically cleavable group is a dienophile, by allowing the dienophile to react with a diene, wherein the dienophile is an eight-membered non-aromatic cyclic alkenylene group, wherein the dienophile satisfies Formula (1a):

wherein A and P each independently are CH 2 or CHX D , provided that at least one is CHX D ; X D is (O—C(O)) p -(L D ) n -(C A ), or O—C(S)-(L D ) n -(C A ), wherein n=0 or 1, wherein p=0 or 1, wherein when p=0, L D or C A is bound to the dienophile via O, S, aromatic N or aromatic NH, Y, Z, X, Q each independently are selected from the group consisting of CR a 2 , C═O, O, and NR b , with at most one of Y, Z, X, and Q being C═O, wherein two R moieties together may form a ring, and with the proviso that no adjacent pairs of atoms are present selected from the group consisting of O—O, and O—NR b ; and wherein one R a,b is optionally bound, directly or via a spacer or spacers S P , to a construct C B ; and

wherein the self-immolative linker L D , in addition to being bound to C A , is also optionally bound, directly or via a spacer or spacers S P , to a construct C B ; and wherein T and G denote H; wherein each R a can independently be H, alkyl, aryl, OR′, SR′, S(═O) 2 R′″, S(═O) 2 NR′R″, SO 3 H, PO S H, NO 2 , CN, CF 3 , CF 2 —R′, NR′R″, C(═O)R′, C(═O)NR′R″, C(═S)NR′R″, NR′C(═O)—R′″, NR′C(═S)—R′″, NR′C(═O)O—R′″, NR′C(═S)O—R′″, NR′C(═O)S—R′″, NR′C(═S)S—R′″, OC(═O)NR′—R′″, SC(═O)NR′—R′″, OC(═S)NR′—R′″, SC(═S)NR′—R′″, NR′C(═O)NR″—R″, or NR′C(═S)NR″—R″, with each R′ and each R″ independently being H, aryl or alkyl and R′″ independently being aryl or alkyl; each R b is independently selected from the group consisting of H, alkyl, aryl, O-aryl, O-alkyl, OH, and C(═O)NR′R″ with R′ and R″ each independently being H, aryl or alkyl, R′CO-alkyl with R′ being H, alkyl, and aryl; wherein C A and C B are each individually a small molecule, an organic molecule, a metal coordination compound, an inorganic molecule, an organometallic molecule, a biomolecule, a drug, a polymer, a resin, a particle, a gel, a surface, a cell, a biological tissue, a pathogen, or a combination thereof; or wherein either or both of C A and C B is present in a binding to a biomolecule; or wherein either or both of C A and C B is comprised in a binding to a polymer, resin, particle, or solid support; or wherein the construct comprises a biomolecule binding moiety, selected from the group consisting of non-covalent binding moieties, and covalent binding moieties;

wherein the diene satisfies formula (4):

wherein R 1 and R 2 each independently are selected from the group consisting of H, alkyl, aryl, S(═O) 2 R′″, S(═O) 2 OR′, C(═O)NR′R″, C(═S)NR′R″, NR′C(═O)OR″, NR′C(═S)OR″, NR′C(═O)SR″, NR′C(═S)SR″, NR′C(═O)NR″R″, and NR′C(═S)NR″R″ with each R′ and each R″ independently being H, aryl or alkyl; with A, B, X, and Y being N; and wherein the diene optionally has a link to a moiety selected from the group consisting of a peptide, a protein, a carbohydrate, a polymer, a resin, a particle, a gel, and a surface.

2. The method according to claim 1 , wherein the dienophile satisfies Formula (1a):

wherein T and G are H, and further wherein A and P each independently are CH 2 or CHX D , provided that at least one is CHX D , X D is (O—C(O)) p -(L D ) n -(C A ), or O—C(S)-(L D ) n -(C A ), wherein p=0 or 1 and n=0 or 1, wherein when p=0, L D or C A is bound to the dienophile via O, S, aromatic N or aromatic NH; wherein one of the bonds PQ, QX, XZ, ZY, YA is part of a fused ring, such that two exocyclic bonds are fixed in the same plane, and provided that PQ and YA are not part of an aromatic 5- or 6-membered ring, or of a conjugated 7-membered ring; when not part of a fused ring P and A are independently CH 2 or CHX D , provided that at least one is CHX D ; when part of a fused ring P and A are independently CH or CX D , provided that at least one is CX D ; the remaining moieties Y, Z, X, and Q of the group (—Y—Z—X-Q-) being independently from each other CR a 2 , S, SO, SO 2 , O, NR b , such that no adjacent pairs of atoms are present selected from the group consisting of O—O, O—NR b , S—NR b , O—S, O—S(O), O—S(O) 2 .

3. The method according to claim 1 , wherein the chemically cleavable group is a trans cyclooctene moiety that satisfies formula (1b):

wherein, in addition to the optional presence of at most two exocyclic bonds fixed in the same plane, each R a independently denotes H, or, in at most three instances, a substituent selected from the group consisting of alkyl, aryl, OR′, SR′, S(═O) 2 R′″, S(═O) 2 NR′R″, SO 3 H, PO 3 H, NO 2 , CN, CF 3 , CF 2 —R′, NR′R″, C(═O)R′, C(═O)NR′R″, C(═S)NR′R″, NR′C(═O)—R′″, NR′C(═S)—R′″, NR′C(═O)O—R′″, NR′C(═S)O—R′″, NR′C(═O)S—R′″, NR′C(═S)S—R′″, OC(═O)NR′—R′″, SC(═O)NR′—R′″, OC(═S)NR′—R′″, SC(═S)NR′—R′″, NR′C(═O)NR″—R″, and NR′C(═S)NR″—R″, with each R′ and each R″ independently being H, aryl or alkyl and R′″ independently being aryl or alkyl;

wherein each R e as above indicated is independently selected from the group consisting of H, alkyl, aryl, OR′, SR′, S(═O) 2 R′″, F, SO 3 H, PO 3 H, NO 2 , CN, CF 3 , CF 2 —R′, C(═O)R′, C(═S)R′, C(═O)NR′R″, C(═S)NR′R″, NR′C(═O)—R′″, NR′C(═S)—R′″, NR′C(═O)O—R′″, NR′C(═S)O—R′″, NR′C(═O)S—R′″, NR′C(═S)S—R′″, NR′C(═O)NR″—R″, and NR′C(═S)NR″—R″, with each R′ and each R″ independently being H, aryl or alkyl and R′″ independently being aryl or alkyl;

wherein two R a,e moieties together may form a ring; and wherein T and G denote H, and X D is (O—C(O)) p -(L D ) n -(C A ), or O—C(S)-(L D ) n -(C A ), wherein p=0 or 1.

4. The method according to claim 1 , wherein the trans-cyclooctene moiety satisfies any one of the following formulae:

and wherein S P is a spacer.

5. The method according to claim 1 , wherein the trans-cyclooctene moiety satisfies any one of the following formulae

wherein =rest of attached C A and L D -C A , wherein L D may optionally comprise C B or S P —C B ,

wherein -----=rest of attached C B or S P —C B .

6. The method according to claim 1 , wherein the trans-cyclooctene moiety satisfies any one of the following formulae

7. The method according to claim 1 , wherein the diene satisfies formula (8a) or (8b):

wherein each R 1 and each R 2 independently are selected from the group consisting of H, alkyl, aryl, CF 3 , CF 2 —R′, NO 2 , OR′, SR′, C(═O)R′, C(═S)R′, OC(═O)R′″, SC(═O)R′″, OC(═S)R′″, SC(═S)R′″, S(═O)R′, S(═O) 2 R′″, S(═O) 2 NR′R″, C(═O)O—R′, C(═O)S—R′, C(═S)O—R′, C(═S)S—R′, C(═O)NR′R″, C(═S)NR′R″, NR′R″, NR′C(═O)R″, NR′C(═S)R″, NR′C(═O)OR″, NR′C(═S)OR″, NR′C(═O)SR″, NR′C(═S)SR″, OC(═O)NR′R″, SC(═O)NR′R″, OC(═S)NR′R″, SC(═S)NR′R″, NR′C(═O)NR″R″, and NR′C(═S)NR″R″ with each R′ and each R″ independently being H, aryl or alkyl, and R′″ independently being aryl or alkyl.

8. The method according to claim 1 , wherein the diene is satisfies a formula selected from the group consisting of (8c), (8d), (8e), (8f), and (8g):

wherein each R 1 and each R 2 independently are selected from the group consisting of H, alkyl, aryl, CF 3 , CF 2 —R′, NO 2 , OR′, SR′, C(═O)R′, C(═S)R′, OC(═O)R′″, SC(═O)R′″, OC(═S)R′″, SC(═S)R″, S(═O)R′, S(═O) 2 R′″, S(═O) 2 NR′R″, C(═O)O—R′, C(═O)S—R′, C(═S)O—R′, C(═S)S—R′, C(═O)NR′R″, C(═S)NR′R″, NR′R″, NR′C(═O)R″, NR′C(═S)R″, NR′C(═O)OR″, NR′C(═S)OR″, NR′C(═O)SR″, NR′C(═S)SR″, OC(═O)NR′R″, SC(═O)NR′R″, OC(═S)NR′R″, SC(═S)NR′R″, NR′C(═O)NR″R″, and NR′C(═S)NR″R″ with each R′ and each R″ independently being H, aryl or alkyl, and R′ independently being aryl or alkyl.

9. The method according to claim 1 , wherein the diene satisfies any one of the formulae:

10. The method according to claim 1 , wherein the diene satisfies any one of the formulae:

11. The method according to claim 1 , wherein the diene satisfies any one of the formulae:

12. The method according to claim 1 , wherein the diene satisfies the formula:

13. The method according to claim 1 , wherein the diene satisfies the formula:

14. The method according to claim 1 , wherein the diene satisfies the formula:

15. The method according to claim 1 , wherein the diene satisfies the formula:

16. The method according to claim 1 , wherein either or both of C A and C B is a biomolecule.

17. The method according to claim 1 , wherein either or both of C A and C B is present in a binding to a biomolecule.

18. The method according to claim 1 , wherein C A or C B is a polymer, resin, particle, solid support.

19. The method according to claim 1 , wherein C A or C B is comprised in a binding to a polymer, resin, particle, or solid support.

20. The method according to claim 1 , wherein the construct comprises, a biomolecule binding moiety, selected from the group consisting of non-covalent binding moieties, and covalent binding moieties.

21. The method according to claim 1 , wherein the dienophile serves as a bioorthogonal linker or mask for reversible biomolecule modification in vitro.

22. The method according to claim 1 wherein Y, Z, X, Q each independently are selected from the group consisting of CR a 2 and O with at most two of Y, Z, X, and Q being O, and wherein T and G are H.

23. The method according to claim 3 wherein the dienophile has a structure according to formula (1b) wherein R e and T and G are H and wherein in at most four instances R a is not a hydrogen.

24. The method according to claim 1 wherein the diene has a structure according to formula (4) wherein R 1 and R 2 each independently are selected from the group consisting of H, alkyl, aryl, wherein A is N; B is N; X is N; and Y is N.

25. The method according to claim 1 , wherein X D is (O—C(O)) p -(L D ) n -(C A ), wherein p=0 or 1, and n=0 or 1.

26. The method according to claim 20 , wherein the non-covalent binding moiety is a biomolecule, biotin or an antibody.

27. The method according to claim 20 , wherein the covalent binding moiety is an N-hydroxysuccinimide ester, a maleimide, an azide, an alkyne, or a photoreactive group.

28. The method according to claim 2 , wherein one R a,b,c or the self-immolative linker L D is bound to C B .

29. The method according to claim 28 , wherein the one R a,b,c or the self-immolative linker L D is bound, via a spacer or spacers S P , to C B .

30. The method according to claim 3 wherein one R a,e or the self-immolative linker L D is bound to C B .

31. The method according to claim 30 wherein one R a,e or the self-immolative linker L D , is bound, via a spacer or spacers S P , to C B .

32. The method according to claim 1 wherein one R a,b or the self-immolative linker L D is bound to C B .

33. The method according to claim 32 wherein one R a,b or the self-immolative linker L D is bound, via a spacer or spacers S P , to C B .

34. The method according to claim 4 wherein S P is a polyethylene glycol (PEG) chain varying from 2 to 200 repeating units or a biopolymer fragment.

35. The method according to claim 34 wherein S P is a biopolymer fragment wherein the biopolymer fragment is an oligopeptide, a polypeptide, a polylactide or a carbohydrate.

36. The method according to claim 1 wherein the diene has a link to a moiety selected from the group consisting of a peptide, a protein, a carbohydrate, a polymer, a resin, a particle, a gel, and a surface.

37. The method according to claim 36 , wherein the polymer is PEG.

Assignments (2)
CHANGE OF ADDRESS Recorded Dec 16, 2021
From: TAGWORKS PHARMACEUTICALS B.V.
To: TAGWORKS PHARMACEUTICALS B.V.
Reel/Frame 058522/0348 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 30, 2015
From: ROBILLARD, MARC STEFAN; VERSTEEGEN, RONNY MATHIEU; TEN HOEVE, WOLTER; ROSSIN, RAFFAELLA
To: TAGWORKS PHARMACEUTICALS B.V.
Reel/Frame 036215/0406 →
Priority Claims (1)
EP 12193911 · Nov 22, 2012 · regional
Continuity (1)
Related Publication 20150344514A1 · Dec 3, 2015
Cited By (3)
US 12,653,914 US 12,714,752 US 12,735,444